Histology |
MRI |
LOH9p,10q,17p |
1p/19qCo-Del |
EGFRAmpl |
PTEN,
TP53,
TERTMut |
MGMTMeth |
Enhancing tumor |
CE |
+ |
+ |
++ |
++ |
+ |
Tumor infiltration with MVP |
CE/NE |
+ |
+ |
+ |
+ |
+ |
Tumor infiltration |
CE/NE |
+/– |
– |
+ |
– |
– |
Edema with or without infiltration |
NE |
– |
– |
– |
– |
– |
|
MRI: magnetic resonance imaging; MVP: microvascular proliferation; CE: contrast
enhancing; NE: non-contrast enhancing; LOH: loss of heterozygosity: EGFR:
epidermal growth factor receptor; PTEN: phosphatase and tensin homologue;
TP53: tumor protein p53; TERT, telomerase reverse transcriptase; MGMT: O6-
methylguanine-DNA methylatransferase.
Note: LOH: The scale corresponds to the occurrence (+) or absence (–) of LOH on
the tested regions; EGFR: The scale corresponds to the number of samples with
gene amplification (++, 100%; +, <50%; –, no amplification); PTEN, TP53, TERT:
The scale corresponds to the number of samples with gene mutations (–, wild
type); MGMT: The scale corresponds to the number of samples with (+) or without
(–) promoter methylation. |
Table 2: Comparison among histologic patterns, MRI and molecular genetics. |